Please assess the completion status of the following clinical trial:

Trial Title: Study of Procalcitonin (PCT)-Guided Antibiotic Use in Severe Sepsis Patients Without Obvious Infection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* hospitalized in resuscitation ward~* severe sepsis symptomatology~* at least 2 SIRS criteria~* no infectious etiology detected~* at least one organ deficiency~Exclusion Criteria:~* the presence of a pathogen agent or infectious centre clearly identified~* pregnancy~* burned~* patients with therapeutic limitation~* recent surgery~* secondary neutropenia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Procalcitonin level (Type: OTHER): duration of the antibiotic treatment guided by procalcitonin level
- physician's appreciation (Type: NO_INTERVENTION): duration of the antibiotic treatment based on physician's appreciation

Based on this trial design, predict the completion outcome and termination type (if applicable).